FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W343303420> ?p ?o ?g. }

• W343303420 endingPage "4264" @default.
• W343303420 startingPage "4259" @default.
• W343303420 abstract "Abstract Prognosis of B-cell chronic lymphocytic leukemia (CLL) is based on clinical staging whose limitation is the failure to assess whether the disease will progress or remain stable in early stage (Binet A, or Rai 0, I, II) patients. We previously reported that soluble CD23 (sCD23), a protein derived from the B-cell membrane CD23 Ag, is selectively elevated in the serum of CLL patients. This prospective study assessed the predictive value of serum sCD23 level measured at study entry on the overall survival of all CLL patients and on disease progression of stage Binet A patients. Prognostic value of repeated measurements of sCD23 over time in stage A patients was also analyzed. One hundred fifty-three CLL patients were prospectively followed with a median follow-up of 78 months. Eight clinical or biological parameters were collected from the date of the first sCD23 measurement. At study entry, by Cox model, Binet staging (P = .0001) and serum sCD23 level (P = .03) appeared as prognostic factors for survival. Patients with sCD23 level above median value (> 574 U/mL) had a significantly worse prognosis than those with lower values (median survival of 53 v 100+ months, P = .0001). During follow-up, sCD23 doubling time increased by 3.2 the risk of death (P = .001). Among stage A patients (n = 100), sCD23 determination at study entry was the sole variable predictive of disease progression, patients with sCD23 level above 574 U/mL had a median time progression of 42 months versus 88 months for those with lower levels (P = .0001). Stage A patients who doubled their sCD23 level exhibited a 15-fold increased risk of progression (P = .0001) and, in addition, the sCD23 increase preceded by 48 months disease progression. We conclude that in CLL patients, serum sCD23 level provides significant additional prognostic information in terms of overall survival. Most interestingly, among early stage patients, sCD23 determination at diagnosis and during the course of the disease may help to the early identification of patients who will rapidly progress to upper stages." @default.
• W343303420 created "2016-06-24" @default.
• W343303420 creator A5007611864 @default.
• W343303420 creator A5021413911 @default.
• W343303420 creator A5025898274 @default.
• W343303420 creator A5035003166 @default.
• W343303420 creator A5052673276 @default.
• W343303420 creator A5053031492 @default.
• W343303420 creator A5054482522 @default.
• W343303420 creator A5070385433 @default.
• W343303420 creator A5074912438 @default.
• W343303420 date "1996-12-01" @default.
• W343303420 modified "2023-10-17" @default.
• W343303420 title "Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia" @default.
• W343303420 cites W143899559 @default.
• W343303420 cites W1484886449 @default.
• W343303420 cites W1516227601 @default.
• W343303420 cites W15344477 @default.
• W343303420 cites W154103547 @default.
• W343303420 cites W1862233028 @default.
• W343303420 cites W1938072709 @default.
• W343303420 cites W1965851569 @default.
• W343303420 cites W1967608740 @default.
• W343303420 cites W1979300931 @default.
• W343303420 cites W2006486191 @default.
• W343303420 cites W2048524562 @default.
• W343303420 cites W2061351840 @default.
• W343303420 cites W2063014195 @default.
• W343303420 cites W2064099782 @default.
• W343303420 cites W2064109411 @default.
• W343303420 cites W2069438089 @default.
• W343303420 cites W2074457690 @default.
• W343303420 cites W2082480273 @default.
• W343303420 cites W2094554555 @default.
• W343303420 cites W2102552995 @default.
• W343303420 cites W2163460786 @default.
• W343303420 cites W2257284526 @default.
• W343303420 cites W2295078395 @default.
• W343303420 cites W2343398839 @default.
• W343303420 cites W2397727880 @default.
• W343303420 cites W2410071112 @default.
• W343303420 cites W2973543785 @default.
• W343303420 cites W3120147220 @default.
• W343303420 cites W2261396814 @default.
• W343303420 cites W2995133996 @default.
• W343303420 doi "https://doi.org/10.1182/blood.v88.11.4259.4259" @default.
• W343303420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8943862" @default.
• W343303420 hasPublicationYear "1996" @default.
• W343303420 type Work @default.
• W343303420 sameAs 343303420 @default.
• W343303420 citedByCount "191" @default.
• W343303420 countsByYear W3433034202012 @default.
• W343303420 countsByYear W3433034202013 @default.
• W343303420 countsByYear W3433034202014 @default.
• W343303420 countsByYear W3433034202015 @default.
• W343303420 countsByYear W3433034202016 @default.
• W343303420 countsByYear W3433034202017 @default.
• W343303420 countsByYear W3433034202018 @default.
• W343303420 countsByYear W3433034202019 @default.
• W343303420 countsByYear W3433034202020 @default.
• W343303420 countsByYear W3433034202021 @default.
• W343303420 countsByYear W3433034202023 @default.
• W343303420 crossrefType "journal-article" @default.
• W343303420 hasAuthorship W343303420A5007611864 @default.
• W343303420 hasAuthorship W343303420A5021413911 @default.
• W343303420 hasAuthorship W343303420A5025898274 @default.
• W343303420 hasAuthorship W343303420A5035003166 @default.
• W343303420 hasAuthorship W343303420A5052673276 @default.
• W343303420 hasAuthorship W343303420A5053031492 @default.
• W343303420 hasAuthorship W343303420A5054482522 @default.
• W343303420 hasAuthorship W343303420A5070385433 @default.
• W343303420 hasAuthorship W343303420A5074912438 @default.
• W343303420 hasBestOaLocation W3433034201 @default.
• W343303420 hasConcept C126322002 @default.
• W343303420 hasConcept C141071460 @default.
• W343303420 hasConcept C141105273 @default.
• W343303420 hasConcept C146357865 @default.
• W343303420 hasConcept C151730666 @default.
• W343303420 hasConcept C159654299 @default.
• W343303420 hasConcept C188816634 @default.
• W343303420 hasConcept C203014093 @default.
• W343303420 hasConcept C2777938653 @default.
• W343303420 hasConcept C2778461978 @default.
• W343303420 hasConcept C34814297 @default.
• W343303420 hasConcept C50382708 @default.
• W343303420 hasConcept C71924100 @default.
• W343303420 hasConcept C86803240 @default.
• W343303420 hasConcept C90924648 @default.
• W343303420 hasConceptScore W343303420C126322002 @default.
• W343303420 hasConceptScore W343303420C141071460 @default.
• W343303420 hasConceptScore W343303420C141105273 @default.
• W343303420 hasConceptScore W343303420C146357865 @default.
• W343303420 hasConceptScore W343303420C151730666 @default.
• W343303420 hasConceptScore W343303420C159654299 @default.
• W343303420 hasConceptScore W343303420C188816634 @default.
• W343303420 hasConceptScore W343303420C203014093 @default.
• W343303420 hasConceptScore W343303420C2777938653 @default.
• W343303420 hasConceptScore W343303420C2778461978 @default.

• next